SHEFF DD Alert (Post #1 of 2) PDMI at .0015 on 10/8/09. PDMI is significantly undervalued compared to other companies in its space. Could easily be a .03 to .05 cent stock based on potential and what the company has in the pipeline. PDMI time is now in the 4th Quarter of 2009. PDMI could be a significant buyout target for big Pharma (Alcon or Bausch & Lomb). Key Forward Looking Events for PDMI are 1) They have Multiple ophthalmic products, 2) 1 pending FDA decision per 10Q (Sales of surgical products are at a standstill pending FDA approval of the Photon TM laser system), and 3) CPT-11 code for reimbursement (“ The Blood Flow Analyzer™ is expected to have a new CPT reimbursement code for Medicare insurance providers issued before the end of 2009”). 4) A big boon for the company is that Paradigm Medical has announced plans to Release Its New Corneal Topographer, the Paravue, in the United States Market! That will occur in the 4th quarter.
Sheff's Station...All Aboard...Sign Up Here!
